% of total assets. Trade Receivables At the end of 2016 and of Q3/2017, the Company reports net trade receivables 229 . 0 0 million THB and 183.37 million THB or equal to 47.71% and 23.17% of total

impressive 4.8% growth. Central bank forecasts for the full year are around 4.5% and with inflation only just breaking into the 1-4% target band (1.2% in Q2) coupled with uncertainty around global trade the

Change Amount % Change Total Revenues 7,792 7,550 242 3.2% Sales and service income 7,624 7,300 324 4.4% Gains on Exchange rate 69 175 -106 -60.3% Other Income 99 75 24 30.8% Cost of Sales and Services

to 28% 2016 2017 % change million Baht million Baht y-on-y Sales and service income 27,747 31,482 13.5% EBITDA 7,494 8,725 16.4% Net profit 2,316 3,594 55.2% Normalized net profit (NNP)* 2,090 2,918

ended 31 March 2018 and 2017 are as follows; Unit: THB million Q1-2018 Q1-2017 % Change 1. Revenue from sales and contract work 1.2 1.2 2.1% 1.1 Turnkey Total Solutions 1.2 1.2 2.1% 2. Revenue from

the year ended 31 December 2018 and 2017 are as follows; Unit: THB million Y2018 Y2017 % Change 1. Revenue from sales and contract work 14.9 21.4 -30.5% 1.1 Turnkey Total Solutions 14.9 21.4 -30.5% 2

ที่ - Translation - PorBor.076 / 2017 November 14, 2017 Subject: Clarification of operating results change from the same period last year by more than 20% To: President The Stock Exchange of Thailand

in Q2/2017. (Unit: Thousand Baht) Revenues Gross Profit Selling Admin Net(loss) profit Q2/17 222,225 80,232 19,957 22,698 (293,091)*** Q2/18 221,202 78,238 21,637 19,916 35,335 Change -1,023 -1,994

of the plant and machineries from an independent engineering expert. The effect of such change in the estimated useful lives of assets to the depreciation charge during the quarter is as below; Unit

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech